These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2179 related items for PubMed ID: 25404858

  • 1. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E.
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM, Silva MA, Donovan JL, Kanaan AO.
    Clin Ther; 2014 Oct 01; 36(10):1454-64.e3. PubMed ID: 25092394
    [Abstract] [Full Text] [Related]

  • 3. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Gómez-Outes A, Terleira-Fernández AI, Lecumberri R, Suárez-Gea ML, Vargas-Castrillón E.
    Thromb Res; 2014 Oct 01; 134(4):774-82. PubMed ID: 25037495
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH.
    Clin Ther; 2017 Jul 01; 39(7):1456-1478.e36. PubMed ID: 28668628
    [Abstract] [Full Text] [Related]

  • 5. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C, Crowther MA.
    Thromb Haemost; 2015 Jun 01; 113(6):1193-202. PubMed ID: 25948149
    [Abstract] [Full Text] [Related]

  • 6. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
    Jugrin AV, Ustyugova A, Urbich M, Lamotte M, Sunderland T.
    Thromb Haemost; 2015 Oct 01; 114(4):778-92. PubMed ID: 26272227
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.
    Coons JC, Albert L, Bejjani A, Iasella CJ.
    Pharmacotherapy; 2020 Mar 01; 40(3):204-210. PubMed ID: 31968126
    [Abstract] [Full Text] [Related]

  • 8. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
    Wang X, Ma Y, Hui X, Li M, Li J, Tian J, Wang Q, Yan P, Li J, Xie P, Yang K, Yao L.
    Cochrane Database Syst Rev; 2023 Apr 14; 4(4):CD010956. PubMed ID: 37058421
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI, Bunz TJ, Turpie AGG.
    Thromb Haemost; 2017 Oct 05; 117(10):1841-1847. PubMed ID: 28640322
    [Abstract] [Full Text] [Related]

  • 10. New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.
    Hirschl M, Kundi M.
    Vasa; 2014 Sep 05; 43(5):353-64. PubMed ID: 25147012
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, Batson S.
    PLoS One; 2016 Sep 05; 11(8):e0160064. PubMed ID: 27487187
    [Abstract] [Full Text] [Related]

  • 12. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A, Lecumberri R, Suárez-Gea ML, Terleira-Fernández AI, Monreal M, Vargas-Castrillón E.
    J Cardiovasc Pharmacol Ther; 2015 Sep 05; 20(5):490-500. PubMed ID: 25802423
    [Abstract] [Full Text] [Related]

  • 13. Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting.
    Jugrin AV, Hösel V, Ustyugova A, De Francesco M, Lamotte M, Sunderland T.
    J Med Econ; 2016 Sep 05; 19(1):1-10. PubMed ID: 26390231
    [Abstract] [Full Text] [Related]

  • 14. New anticoagulants in the management of venous thromboembolism in women.
    Piovella F, Irina Iosub D.
    Thromb Res; 2015 Feb 05; 135 Suppl 1():S5-7. PubMed ID: 25903537
    [Abstract] [Full Text] [Related]

  • 15. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
    Elsebaie MAT, van Es N, Langston A, Büller HR, Gaddh M.
    J Thromb Haemost; 2019 Apr 05; 17(4):645-656. PubMed ID: 30690830
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
    Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.
    Int Angiol; 2014 Aug 05; 33(4):301-8. PubMed ID: 25056161
    [Abstract] [Full Text] [Related]

  • 17. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
    Sobieraj DM, Coleman CI, Pasupuleti V, Deshpande A, Kaw R, Hernandez AV.
    Thromb Res; 2015 May 05; 135(5):888-96. PubMed ID: 25795564
    [Abstract] [Full Text] [Related]

  • 18. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT, Dobromirski M, Gurwith MM.
    Thromb Res; 2014 Feb 05; 133(2):139-48. PubMed ID: 24182642
    [Abstract] [Full Text] [Related]

  • 19. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE, Cavallazzi R.
    PLoS One; 2015 Feb 05; 10(11):e0143252. PubMed ID: 26587983
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 109.